This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
